Wave Life Sciences to Webcast Conference Call of Third Quarter 2020 Financial Results on November 9, 2020

Rhea-AI Summary

Wave Life Sciences (Nasdaq: WVE) will host a live webcast and conference call on November 9, 2020, at 8:30 a.m. ET to discuss its third quarter 2020 financial results and provide a business update. Investors can access the webcast via the Investor Relations section of the company’s website. Wave focuses on developing genetic medicines for severe diseases using its proprietary PRISM platform, which enables the design and production of stereopure oligonucleotides.

Positive

• The upcoming call will provide insights into Q3 2020 financial results.
• Wave is focused on developing life-changing genetic medicines.

Negative

• None.

CAMBRIDGE, Mass., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Monday, November 9, 2020, to discuss its third quarter 2020 financial results and provide a business update.

The webcast of the conference call may be accessed by visiting the “Events” section in the Investor Relations page of the Wave Life Sciences website at http://ir.wavelifesciences.com. The live teleconference may be accessed by dialing (866) 220-8068 (domestic) or (470) 495-9153 (international) and entering conference ID: 3563968. Following the conference call, an archived version of the call will be available on the website.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contacts:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Graham Morrell
781-686-9600
gmorrell@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

FAQ

When will Wave Life Sciences announce its Q3 2020 financial results?

Wave Life Sciences will announce its Q3 2020 financial results on November 9, 2020.

How can I access the Wave Life Sciences conference call?

You can access the Wave Life Sciences conference call by visiting the Investor Relations section of their website or by dialing (866) 220-8068 for domestic callers.

What is the focus of Wave Life Sciences?

Wave Life Sciences focuses on developing genetic medicines for patients with severe diseases using their proprietary PRISM platform.

Is a replay of the Wave Life Sciences conference call available?

Yes, an archived version of the conference call will be available on the Wave Life Sciences website following the live event.